1
2
3
CSL Ltd (ASX)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
交易时间表 (UTC)
开放
立即关闭
关闭日期
开幕日期
于
-
这将显示您所在时区的开放时间
(UTC)
| 滴答声 | CSL |
| 合同价值 | 100 shares |
| 最大杠杆率 | 1:1 |
掉期历史
| 日期 | Short Swap (%) | Long Swap (%) | 无数据 |
|---|
| 最低交易量 | 0.01 地段 |
| 最大交易量 | 100 地段 |
| 套期保值保证金 | 50% |
保证金要求
| 美元风险 | 应用的最大杠杆 | 浮动保证金 |
|---|
